Octreotide Acetate Injection

SECTION 2: Hazards identification

EMERGENCY OVERVIEW: Material is a clear, colorless liquid. Eye and skin irritant. Avoid contact with eyes, skin and clothing. Do not taste or swallow. Wash thoroughly after handling. Symptoms of Overexposure by Route of Exposure: This material is intended for injection under the supervision of physicians. Injection setting. Medical personnel are not anticipated to experience over-exposures to the therapeutic doses Inhalation: Inhalation of significant amounts of the product is not anticipated to occur because of the small size of individual containers. Contact with Skin or Eyes: Contact may cause irritation. Effects may include stinging, watering, redness and swelling of the eyes and redness, itching, burning and skin damage. Ingestion: Ingestion is not an anticipated route of occupational exposure. However, it is considered to be highly toxic based on animal data. Symptoms similar to those identified under injection may occur. Injection: Local redness and pain are the primary symptoms of accidental injection in an occupational of this product. However, effects including gall stones, decreased pulse, cardiac arrhythmias, diarrhea, Acetate nausea, abdominal pain, hyper/hypoglycemia and hypothyroidism may occur. See package insert for abdominal pain, hyper/hypoglycemia and hypothyroidism may occur. other adverse reactions associated with therapeutic doses of this product.

Potential health effects

or Risks From Exposure (An explanation in lay terms) Acute: The primary health effects anticipated in an occupational setting include irritation of eyes and skin as well as redness and local swelling after accidental injection. In case of over-exposure by injection, effects such as gall stones, decreased pulse, cardiac arrhythmias, diarrhea, nausea, Cancer: Not expected to cause cancer (see Section 11). Chronic: None known. Pre-Existing Medical Conditions: Conditions aggravated by exposure may include skin disorders.